Adaptimmune Therapeutics
ADAP
#8446
Rank
C$0.22 B
Marketcap
$0.87
Share price
0.82%
Change (1 day)
31.04%
Change (1 year)

Market capitalization of Adaptimmune Therapeutics (ADAP)

Market cap: C$0.22 Billion

As of December 2024 Adaptimmune Therapeutics has a market cap of C$0.22 Billion. This makes Adaptimmune Therapeutics the world's 8446th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Adaptimmune Therapeutics from 2015 to 2024

End of year Market Cap

Year Marketcap Change
2024C$0.22 B-6.96%
2023C$0.23 B-26.4%
2022C$0.32 B-56.52%
2021C$0.74 B-29.83%
2020C$1.06 B545.43%
2019C$0.16 B-79.88%
2018C$0.81 B4.1%
2017C$0.78 B104.23%
2016C$0.38 B-67.47%
2015C$1.18 B

End of Day market cap according to different sources

On Dec 22nd, 2024 the market cap of Adaptimmune Therapeutics was reported to be:

C$0.22 Billion
by Nasdaq info icon info icon
C$0.22 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
C$2.00 B 800.36%๐Ÿ‡บ๐Ÿ‡ธ USA
C$57.21 M-74.26%๐Ÿ‡บ๐Ÿ‡ธ USA
C$1.18 B 434.72%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
C$13.65 B 6,042.07%๐Ÿ‡บ๐Ÿ‡ธ USA